In The News,
ADVI CEO Marc Samuels caught up with Modern Healthcare to discuss the likelihood of Congress enacting drug pricing reforms during an election year
[el-text]
Written by Rachel Cohrs
***excerpt***
“Enacting comprehensive drug-pricing reforms during a presidential election year is already an unlikely prospect…” said Marc Samuels, CEO of healthcare consulting firm ADVI.
***end excerpt***
[/el-text]